1887

Abstract

remains a significant cause of morbidity and mortality and, therefore, a burden on healthcare systems. Our aim was to estimate the current rate of nasal carriage in the general population and to determine the feasibility of nasal self-swabbing as a means of detection. Two thousand people (1200 adults and 800 children) from a single NHS general practice in Southampton, UK, were randomly selected from a general practice age sex register, stratified by age and sex, and invited to undertake nasal self-swabbing in their own home. Overall, 362 (32.5 %) swabs from adults and 168 (22 %) from children were returned. Responses were greater for adults and those of increased age, female gender and decreasing socio-economic deprivation. The overall estimated practice carriage rate of directly standardized for age sex was 28 % [95 % confidence interval (CI) 26.1–30.2 %]. Carriage of meticillin-susceptible was 27 % (95 % CI 26.1–30.2 %), whilst that of meticillin-resistant was 1.9 % (95 % CI 0.7–3.1 %). Although nasal self-swabbing rates were relatively low, they are comparable to other studies and may allow large population-based carriage studies to be undertaken at relatively low cost. Importantly, this study updates prevalence data for carriage in the community.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.051854-0
2013-03-01
2020-07-07
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/3/437.html?itemId=/content/journal/jmm/10.1099/jmm.0.051854-0&mimeType=html&fmt=ahah

References

  1. Abudu L., Blair I., Fraise A., Cheng K. K. 2001; Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol Infect 126:351–356 [CrossRef][PubMed]
    [Google Scholar]
  2. Bignardi G. E., Lowes S. 2009; MRSA screening: throat swabs are better than nose swabs. J Hosp Infect 71:373–374 [CrossRef][PubMed]
    [Google Scholar]
  3. Department of Health 2002 Getting ahead of the curve: a strategy for combating infectious diseases (including other aspects of health protection). Department of Health, London
  4. Department of Health 2007 A simple guide to MRSA. Department of Health, London
  5. Green S. M., Marsh P., Ahmad N., Jefferies J. M., Clarke S. C. 2010; Characterization of community and hospital Staphylococcus aureus isolates in Southampton, UK. J Med Microbiol 59:1084–1088 [CrossRef][PubMed]
    [Google Scholar]
  6. Grundmann H., Tami A., Hori S., Halwani M., Slack R. 2002; Nottingham Staphylococcus aureus population study: prevalence of MRSA among elderly people in the community. BMJ 324:1365–1366 [CrossRef][PubMed]
    [Google Scholar]
  7. Ma X. X., Sun D. D., Wang S., Wang M. L., Li M., Shang H., Wang E. H., Luo E. J. 2011; Nasal carriage of methicillin-resistant Staphylococcus aureus among preclinical medical students: epidemiologic and molecular characteristics of methicillin-resistant S. aureus clones. Diagn Microbiol Infect Dis 70:22–30 [CrossRef][PubMed]
    [Google Scholar]
  8. McDonald R. R., Antonishyn N. A., Hansen T., Snook L. A., Nagle E., Mulvey M. R., Levett P. N., Horsman G. B. 2005; Development of a triplex real-time PCR assay for detection of Panton-Valentine leukocidin toxin genes in clinical isolates of methicillin-resistant Staphylococcus aureus. . J Clin Microbiol 43:6147–6149[PubMed] [CrossRef]
    [Google Scholar]
  9. Maudsley J., Stone S. P., Kibbler C. C., Iliffe S. R., Conaty S. J., Cookson B. D., Duckworth G. J., Johnson A., Wallace P. G. 2004; The community prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in older people living in their own homes: implications for treatment, screening and surveillance in the UK. J Hosp Infect 57:258–262 [CrossRef][PubMed]
    [Google Scholar]
  10. Nathwani D., Morgan M., Masterton R. G., Dryden M., Cookson B. D., French G., Lewis D. British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections 2008; Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 61:976–994 [CrossRef][PubMed]
    [Google Scholar]
  11. O’Connell T., Thornton L., O’Flanagan D., Staines A., Connell J., Dooley S., McCormack G. 2001; Oral fluid collection by post for viral antibody testing. Int J Epidemiol 30:298–301 [CrossRef][PubMed]
    [Google Scholar]
  12. Otter J. A., Havill N. L., Boyce J. M., French G. L. 2009; Comparison of community-associated methicillin-resistant Staphylococcus aureus from teaching hospitals in London and the USA, 2004–2006: where is USA300 in the UK?. Eur J Clin Microbiol Infect Dis 28:835–839 [CrossRef][PubMed]
    [Google Scholar]
  13. Rollason J., Bastin L., Hilton A. C., Pillay D. G., Worthington T., McKeon C., De P., Burrows K., Lambert P. A. 2008; Epidemiology of community-acquired meticillin-resistant Staphylococcus aureus obtained from the UK West Midlands region. J Hosp Infect 70:314–320 [CrossRef][PubMed]
    [Google Scholar]
  14. Senn L., Basset P., Nahimana I., Zanetti G., Blanc D. S. 2012; Which anatomical sites should be sampled for screening of methicillin-resistant Staphylococcus aureus carriage by culture or by rapid PCR test?. Clin Microbiol Infect 18:E31–E33 [CrossRef][PubMed]
    [Google Scholar]
  15. Voyich J. M., Otto M., Mathema B., Braughton K. R., Whitney A. R., Welty D., Long R. D., Dorward D. W., Gardner D. J. other authors 2006; Is Panton–Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?. J Infect Dis 194:1761–1770 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.051854-0
Loading
/content/journal/jmm/10.1099/jmm.0.051854-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error